Diffuse Large B-cell Lymphoma
📧 Sign up to get email alerts when something new happens for Diffuse Large B-cell Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: CCI-779 in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia [Phase 2]
Phase 2 study of temsirolimus (CCI-779) in relapsed or refractory chronic lymphocytic leukemia has been terminated. The study also involved …
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Oxaliplatin in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
A Phase 2 study evaluated oxaliplatin in patients with relapsed or refractory non-Hodgkin lymphoma across multiple subtypes and has complete…
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Treatment Resistance Related With Gene Expression Profile of Diffuse Large B-cell Lymphoma
A completed clinical trial from Samsung Medical Center investigates treatment resistance in diffuse large B-cell lymphoma based on gene expr…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: SB-715992 in Treating Patients With Metastatic or Unresectable Solid Tumors or Hodgkin's or Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 trial of SB-715992 in patients with metastatic or unresectable solid tumors and various Hodgkin's and non-Hodgkin's lymphomas has be…
-
CLINICAL_TRIALS trial_result · 2013-01-11Clinical Trial Update: Bryostatin and Vincristine in B-Cell Malignancies [Phase 1]
Phase 1 trial evaluating Bryostatin-1 in combination with Vincristine in several recurrent or refractory B-cell malignancies; the study has …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Bryostatin 1 Plus Vincristine in Treating Patients With Progressive or Relapsed Non-Hodgkin's Lymphoma After Bone Marrow or Stem Cell Transplantation [Phase 2]
A Phase 2 clinical trial evaluating Bryostatin-1 in combination with vincristine for progressive or relapsed non-Hodgkin lymphoma after bone…
-
CLINICAL_TRIALS trial_result · 2013-01-10Clinical Trial Update: Gossypol, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery [Phase 1]
Phase 1 trial evaluating the combination of gossypol, paclitaxel, and carboplatin in patients with metastatic or unresectable solid tumors, …
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Bortezomib in Treating Patients With Diffuse Large B-Cell Lymphoma That Is Refractory To Chemotherapy [Phase 2]
This update covers a Phase 2 trial of bortezomib in patients with diffuse large B-cell lymphoma that is refractory to chemotherapy. The stud…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: Sorafenib in Treating Patients With Metastatic or Unresectable Solid Tumors, Multiple Myeloma, or Non-Hodgkin's Lymphoma With or Without Impaired Liver or Kidney Function [Phase 1]
Phase 1 trial of sorafenib in patients with metastatic or unresectable solid tumors, multiple myeloma, or non-Hodgkin lymphomas; the study h…
-
CLINICAL_TRIALS trial_result · 2013-01-07Clinical Trial Update: S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of rituximab-containing chemotherapy with or without oblimersen for advanced diffuse large B-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: Zevalin Twice in Aggressive Non-Hodgkin Lymphoma [Phase 2]
Phase 2 study of Zevalin (ibritumomab tiuxetan) in aggressive diffuse large B-cell lymphoma was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma [Phase 3]
A Phase 3 trial evaluating bevacizumab in combination with rituximab and CHOP for diffuse large B-cell lymphoma was terminated, with results…
-
CLINICAL_TRIALS trial_result · 2012-12-19Clinical Trial Update: Combination Chemo, Rituximab, and Bevacizumab in Older Patients With Stage II-IV Diffuse Large B-Cell Lymphoma [Phase 2]
Phase 2 trial evaluating the safety and efficacy of combining chemotherapy with rituximab and bevacizumab in older adults with stage II-IV d…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Phase II Study of 131I-rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]
A Phase II clinical trial evaluating 131I-rituximab for relapsed or refractory diffuse large B-cell lymphoma is listed with an unknown curre…
-
CLINICAL_TRIALS trial_result · 2012-10-19Clinical Trial Update: MDX-010 in Treating Patients With Recurrent or Refractory Lymphoma [Phase 1, Phase 2]
This clinical trial update reports on MDX-010 (ipilimumab) in treating recurrent or refractory lymphoma across multiple subtypes, with the s…
-
CLINICAL_TRIALS trial_result · 2012-10-05Clinical Trial Update: Flavopiridol to Treat Relapsed Mantle Cell Lymphoma or Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluating flavopiridol for relapsed mantle cell lymphoma or diffuse large B-cell lymphoma has results posted.
-
CLINICAL_TRIALS trial_result · 2012-09-27Clinical Trial Update: Intensified 1st Cycle Rituximab Plus 8th Cycles of R-CHOP Chemotherapy in Patients With Advanced or Bulky CD20+ Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]
A Phase 2 study evaluating intensified first-cycle Rituximab followed by eight cycles of R-CHOP chemotherapy in patients with advanced or bu…
-
CLINICAL_TRIALS trial_result · 2012-09-19Clinical Trial Update: PXD101 in Treating Patients With Relapsed or Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of belinostat (PXD101) in relapsed or refractory aggressive B-cell non-Hodgkin lymphoma has completed, with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-09-05Clinical Trial Update: Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]
This Phase II trial evaluated the combination of ofatumumab with ICE or DHAP chemotherapy in relapsed/refractory diffuse large B-cell lympho…
-
CLINICAL_TRIALS trial_result · 2012-08-27Clinical Trial Update: Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) [Phase 2]
Phase 2 study evaluating lenalidomide plus rituximab (Revlirit Regimen) in elderly patients with relapsed/refractory Diffuse large B-cell ly…
-
CLINICAL_TRIALS trial_result · 2012-08-22Clinical Trial Update: FR901228 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial of FR901228 (romidepsin) in relapsed or refractory non-Hodgkin's lymphoma was terminated, with results posted.
-
CLINICAL_TRIALS trial_result · 2012-07-31Clinical Trial Update: Coproporphyrine Isomers and Methotrexate Elimination
This completed clinical trial update investigates coproporphyrin isomer profiles and methotrexate elimination in patients with Central Nervo…
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: A Study of Rituximab Alternative Dosing Rate in Patients With Previously Untreated Diffuse Large B-cell or Follicular Non-Hodgkin's Lymphoma (RATE) [Phase 3]
Phase 3 study evaluating alternative dosing rate of rituximab in previously untreated diffuse large B-cell lymphoma and follicular lymphoma;…
-
CLINICAL_TRIALS trial_result · 2012-04-17Clinical Trial Update: Dosimetry/Validation Study of 131Iodine-Anti B1 (Murine) Radioimmunotherapy for Chemotherapy Refractory Low Grade B Cell Lymphomas and Low Grade Lymphomas That Have Transformed to Higher Grade Histologies [Phase 2]
Phase 2 dosimetry/validation study of 131Iodine-Anti B1 (murine) radioimmunotherapy in chemotherapy-refractory low-grade B-cell lymphomas, i…
-
CLINICAL_TRIALS trial_result · 2012-02-20Clinical Trial Update: Rituximab Combined With ESHAP in Patients With Relapse or Refractory Diffuse Large B Cell Lymphoma (DLBCL) [Phase 2]
A Phase 2 study evaluating rituximab plus the ESHAP chemotherapy regimen in relapsed or refractory diffuse large B-cell lymphoma has complet…